Unveiling SSR4: a promising biomarker in esophageal squamous cell carcinoma
BackgroundEsophageal squamous cell carcinoma (ESCC) represents a frequent cancer with a poor prognosis. Altered glucose metabolism contributes factor to ESCC progression. In our previous study, signal sequence receptor subunit delta (SSR4) was included…